1 asset in Alpha Thalassemia Spectrum
Therapeutic assets addressing Alpha Thalassemia Spectrum, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Mitapivat Alpha Thalassemia Spectrum | Agios Pharmaceuticals, Inc. | P3 | B (60) |